Citigroup »

Biosante Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $788k 14k 55.14
2023-09-30 $497k 8.6k 58.06
2023-03-31 $250k 6.3k 39.72
2022-12-31 $321k 8.0k 40.23
2022-09-30 $223k 6.9k 32.16
2021-12-31 $398k 8.6k 46.09
2021-03-31 $53k 1.5k 36.25
2020-12-31 $90k 3.1k 28.91
2020-09-30 $73k 2.6k 28.13
2020-06-30 $191k 5.9k 32.39
2020-03-31 $281k 6.8k 41.01
2019-12-31 $561k 9.3k 60.09
2019-09-30 $6.3M 86k 72.85
2019-06-30 $1.4M 17k 82.25
2019-03-31 $232k 3.3k 70.22
2018-12-31 $2.1M 47k 45.06
2018-09-30 $2.7M 49k 56.54
2018-06-30 $1.6M 23k 66.83
2018-03-31 $2.4M 41k 58.24
2017-12-31 $2.3M 36k 64.47
2017-09-30 $1.7M 33k 52.47
2017-06-30 $908k 19k 46.82
2017-03-31 $1.5M 31k 49.51
2016-12-31 $2.5M 41k 60.62
2016-09-30 $726k 11k 66.40
2016-06-30 $286k 5.1k 55.87
2015-12-31 $0 427 0.00
2015-09-30 $38k 932 41.18
2015-06-30 $45k 741 60.00
2014-09-30 $7.2k 271 26.42